Does diabetes always confer coronary heart disease risk equivalent to a prior myocardial infarction?: implications for prevention.
作者信息
Boyko Edward J, Meigs James B
出版信息
Diabetes Care. 2011 Mar;34(3):782-4. doi: 10.2337/dc10-1958.
Abstract
摘要
相似文献
1
Does diabetes always confer coronary heart disease risk equivalent to a prior myocardial infarction?: implications for prevention.糖尿病所带来的冠心病风险是否始终等同于既往心肌梗死？：对预防工作的启示
Diabetes Care. 2011 Mar;34(3):782-4. doi: 10.2337/dc10-1958.
2
Association between silent coronary artery disease, diabetes, and autonomic neuropathy. Fact of fallacy?无症状性冠状动脉疾病、糖尿病与自主神经病变之间的关联。事实还是谬误？
Diabetes Care. 1992 Feb;15(2):288-92. doi: 10.2337/diacare.15.2.288.
3
[Type 2 diabetes: an equivalent of coronary heart disease].2型糖尿病：等同于冠心病
Ther Umsch. 2002 Aug;59(8):379. doi: 10.1024/0040-5930.59.8.379.
4
[Autonomic heart rhythm regulation and its alteration in myocardial infarction and diabetes mellitus].[自主心律调节及其在心肌梗死和糖尿病中的改变]
Medicina (Kaunas). 2010;46(3):219-30.
5
Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study.患有慢性肾脏病的人群与患有糖尿病的人群相比，发生冠心病事件的风险：一项基于人群的队列研究。
Lancet. 2012 Sep 1;380(9844):807-14. doi: 10.1016/S0140-6736(12)60572-8. Epub 2012 Jun 19.
6
Diabetes mellitus and acute myocardial infarction: more data supporting a poorer microvasculature reperfusion.糖尿病与急性心肌梗死：更多数据支持较差的微血管再灌注情况。
Am Heart J. 2003 Aug;146(2):E6. doi: 10.1016/S0002-8703(03)00166-2.
7
Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction.首次心肌梗死患者的冠心病危险因素数量与死亡率。
JAMA. 2011 Nov 16;306(19):2120-7. doi: 10.1001/jama.2011.1654.
8
Residual left ventricular pump function following acute myocardial infarction in postmenopausal diabetic women.
Coron Artery Dis. 1994 Mar;5(3):237-42. doi: 10.1097/00019501-199403000-00009.
9
Is diabetes a coronary risk equivalent? Systematic review and meta-analysis.糖尿病是否等同于冠心病风险？系统评价与荟萃分析。
Diabet Med. 2009 Feb;26(2):142-8. doi: 10.1111/j.1464-5491.2008.02640.x.
10
The myocardium after repeated infarction.反复梗死之后的心肌
JAMA. 1977 Dec 12;238(24):2637.
引用本文的文献
1
Diabetes, diabetes severity, and coronary heart disease risk equivalence: REasons for Geographic and Racial Differences in Stroke (REGARDS).糖尿病、糖尿病严重程度与冠心病风险等效性：中风地理和种族差异原因研究（REGARDS）
Am Heart J. 2016 Nov;181:43-51. doi: 10.1016/j.ahj.2016.08.002. Epub 2016 Aug 12.
2
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study.利钠肽和高敏肌钙蛋白用于预测糖尿病患者的心血管风险：社区动脉粥样硬化风险（ARIC）研究
Diabetes Care. 2016 May;39(5):677-85. doi: 10.2337/dc15-1760. Epub 2016 Jan 6.
3
Comparison of different vascular risk engines in the identification of type 2 diabetes patients with high cardiovascular risk.不同血管风险评估工具在识别心血管高风险2型糖尿病患者中的比较
BMC Cardiovasc Disord. 2015 Oct 13;15:121. doi: 10.1186/s12872-015-0120-3.
4
Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.美国成年人中，未确诊糖尿病者的 LDL 胆固醇意识、治疗和控制水平低于确诊糖尿病者。
Diabetes Care. 2013 Sep;36(9):2734-40. doi: 10.2337/dc12-2318. Epub 2013 May 1.
5
Mortality rates in trials of subjects with type 2 diabetes.2 型糖尿病患者临床试验中的死亡率。
J Am Heart Assoc. 2012 Feb;1(1):8-15. doi: 10.1161/JAHA.111.000059. Epub 2012 Feb 20.
本文引用的文献
1
Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.与非糖尿病首次急性心肌梗死患者相比，2 型糖尿病患者的长期心血管风险：来自南欧的一项基于人群的队列研究。
Diabetes Care. 2010 Sep;33(9):2004-9. doi: 10.2337/dc10-0560. Epub 2010 Jun 8.
2
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.阿司匹林用于糖尿病患者心血管事件的一级预防：美国糖尿病协会立场声明、美国心脏协会科学声明及美国心脏病学基金会专家共识文件
Diabetes Care. 2010 Jun;33(6):1395-402. doi: 10.2337/dc10-0555.
3
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.2 型糖尿病患者无症状心肌梗死的发生率和预测因素及非诺贝特的作用：来自非诺贝特干预和糖尿病事件降低（FIELD）研究的分析。
Eur Heart J. 2010 Jan;31(1):92-9. doi: 10.1093/eurheartj/ehp377. Epub 2009 Sep 29.
4
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.阿司匹林用于血管疾病的一级和二级预防：来自随机试验的个体参与者数据的协作荟萃分析
Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.
5
Is diabetes a coronary risk equivalent? Systematic review and meta-analysis.糖尿病是否等同于冠心病风险？系统评价与荟萃分析。
Diabet Med. 2009 Feb;26(2):142-8. doi: 10.1111/j.1464-5491.2008.02640.x.
6
10-year follow-up of intensive glucose control in type 2 diabetes.2型糖尿病强化血糖控制的10年随访
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
7
Numeracy skill and the communication, comprehension, and use of risk-benefit information.算术技能以及风险效益信息的沟通、理解和使用。
Health Aff (Millwood). 2007 May-Jun;26(3):741-8. doi: 10.1377/hlthaff.26.3.741.
8
What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits).什么更危险，是你的阿司匹林还是你的汽车？理性思考药物风险（和益处）。
Health Aff (Millwood). 2007 May-Jun;26(3):636-46. doi: 10.1377/hlthaff.26.3.636.
9
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.糖尿病患者心血管疾病的一级预防：美国心脏协会和美国糖尿病协会的科学声明
Diabetes Care. 2007 Jan;30(1):162-72. doi: 10.2337/dc07-9917.
10
Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine.药物遗传学与药物基因组学：起源、现状及个性化医疗的前景
Pharmacogenomics J. 2006 May-Jun;6(3):162-5. doi: 10.1038/sj.tpj.6500361.
Zotero 插件